Esperion Therapeutics, Inc. (ESPR)
3.81
+0.02
(+0.53%)
USD |
NASDAQ |
Dec 10, 09:53
Esperion Therapeutics EPS Diluted (Quarterly): -0.1561 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Ovid Therapeutics, Inc. | -0.171 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.33M |
| Revenue (Quarterly) | 87.31M |
| Total Expenses (Quarterly) | 118.64M |
| Enterprise Value | 1.404B |
| Gross Profit Margin (Quarterly) | 52.71% |
| Profit Margin (Quarterly) | -35.89% |
| Earnings Yield | -14.06% |
| Normalized Earnings Yield | -13.91 |